Jeuveau to Challenge Botox in the Fight Against Frown Lines

Jeuveau Northern Virginia

Since gaining FDA-approval in 2002, Botox has faced little competition from other antiaging injectables. However, Jeuveau is a new neurotoxin that is poised to go head-to-head with Botox in the fight against frown lines.

So, what is Jeuveau? How does it work? Is Jeuveau as effective as Botox?

If you’re curious about this treatment option, continue reading to learn all about Jeuveau in Northern Virginia, including the reason why patients may switch from Botox.

What Is Jeuveau?

Jeuveau is the newest FDA-approved antiaging injectable for frown lines. Like Botox, Dysport, and Xeomin, Jeuveau is a neurotoxin composed of botulinum toxin type A. It relaxes wrinkles by blocking signals between nerves and targeted facial muscles and preventing muscle contraction.

Jeuveau and Botox – Similar Efficacy and Safety Profile

In clinical trials, Jeuveau was found to produce results that were consistent with those of Botox and did not yield any concerning side effects.

Both neuromodulators are able to smooth frown lines for 3-4 months, without any downtime or recovery.

20-30% Price Reduction Makes Jeuveau a Worthy Botox Competitor

Despite these similarities, there is one significant difference between Jeuveau and Botox – price. Jeuveau costs 20-30% less than Botox, which could help it gain a competitive advantage in the fight against frown lines.

This price reduction will be especially appealing when comparing the cost of Botox units versus the cost of Jeuveau units.

What’s more, the reduced price may make Jeuveau more accessible to patients seeking neurotoxin injections or those looking for off-label treatment.

Learn More About Jeuveau for Frown Lines

If you are considering a neurotoxin treatment and would like to learn more about Jeuveau in Northern Virginia, please contact our office today to schedule a consultation with one of our highly skilled and talented injectors.